Two isoforms of estrogen receptor (ER) have been described: ER␣ and ER␤. The initial gene targeting of ER␣, consisting in the introduction of a Neo cassette in exon 1 [␣ERKO, hereafter called ER␣-Neo KO (knockout)], was reported in 1993. More recently, another mouse deficient in ER␣ because of the deletion of exon 2 (ER␣KO, hereafter called ER␣-⌬2 KO) was generated. In ovariectomized ER␣-wild-type mice, estradiol (E2) increases uterine weight and basal production of endothelial nitric oxide (NO). Both of these effects are abolished in ER␣-⌬2 KO mice. In contrast, we show here that both of these effects of E 2 are partially (uterine weight) or totally (endothelial NO production) preserved in ER␣-Neo KO. We also confirm the presence of two ER␣ mRNA splice variants in uterus and aorta from ER␣-Neo KO mice. One of them encodes a chimeric ER␣ protein (ER␣55), partially deleted in the A͞B domain, that was detected in both uterus and aorta by Western blot analysis. The other ER␣ mRNA splice variant codes for an isoform deleted for the A͞B domain (ER␣46), which was detected in uterus of ER␣-Neo KO, and wild-type mice. This protein isoform was not detected in aorta. The identification of these two N-terminal modified isoforms in uterus, and at least one of them in aorta, probably explains the persistence of the E 2 effects in ER␣-Neo KO mice. Furthermore, ER␣-Neo KO mice may help in the elucidation of the specific functions of full-length ER␣ (ER␣66) and ER␣46, both shown to be physiologically generated in vivo.
C ardiovascular diseases resulting from atherosclerosis are a leading cause of death in Western societies (1) . Epidemiological studies show men and postmenopausal women are at a higher risk for such diseases than premenopausal women, suggesting that estrogen may be cardioprotective (2, 3) . Although lipoprotein changes occur in premenopausal women and postmenopausal women receiving hormone replacement therapy, in large-scale studies with adjustments for multiple risk factors, only 25-50% of the beneficial effects of estrogen seem to be caused by lipoprotein effects (4) . Several large animal species including non-human primate (5), swine (6) , and rabbits (7) and, more recently, apolipoprotein E-deficient mice (8, 9) have been used to assess these nonlipid effects of estrogen. They showed that effects on endothelium (10, 11) may contribute to the cardioprotection observed in humans.
To date, two estrogen receptor (ER) isoforms, encoded by two different genes, have been described: ER␣ and ER␤. Lubahn et al. (12) first reported the gene targeting of ER␣ (␣ERKO), consisting in the introduction of a Neo cassette in the NotI site of exon 1, hereafter designated as the ER␣-Neo knockout (KO) mouse (Fig. 1) . Although the reproductive function is abolished in these mice, several effects of estradiol (E 2 ) persist, such as a certain degree of uterine hypertrophy or the prevention of carotid media hyperplasia in response to endovascular artery injury (13) . In addition, Couse et al. (14) reported that ER␣-Neo KO mice encode, through alternative splicing, a chimeric ER␣ protein of 55 kDa (ER␣55), in which 64 aa residues, belonging mainly to the B region (see Fig. 3B ), have been partially deleted from the N-terminal A͞B regions of ER␣ and replaced by 7 aa encoded by a small portion of the Neo insert. Although they failed to demonstrate directly the immunoreactive presence of this altered isoform in tissues, they have overexpressed and characterized this mutant in vitro and showed that it possesses a residual estrogen-dependent transcriptional activity. It has also been reported that human umbilical cultured endothelial cells contain two prominent ER␣ immunoreactive species, one of the expected 66-kDa mass corresponding to full-length ER␣ and the other of 46 kDa, which may separately trigger genomic or rapid signaling responses (15) . Tissue-specific expression of such ER␣ mRNA variants, including aorta, has previously been described in the mouse (16) and human (17) .
More recently, Dupont et al. (18) generated mice deficient in either ER␣ (ER␣KO, designated ER␣-⌬2 KO mouse hereafter) or ER␤ (designated ER␤KO). ER␣-⌬2 KO mouse has the deletion of exon 2 ( Fig. 1 ) and corresponds to a complete and unambiguous inactivation of ER␣ (18) . The use of these two ER␣ and ER␤ KOs allowed us to unambiguously demonstrate that ER␣ mediates the endothelial effects of E 2 . Whereas E 2 accelerates re-endothelialization and increases endothelial production of endothelium-derived relaxing factor (EDRF)͞NO in ovariectomized wild-type (WT) and ER␤KO mice, these effects of E 2 are completely lost in ER␣-⌬2 KO mouse (19, 20) .
To evaluate the possible activities of ER␣ lacking the B region, we sought to compare the effects of E 2 on the endothelial production of EDRF͞NO in WT ER␣ (ER␣-WT), ER␣-⌬2 KO, and ER␣-Neo KO mice. America) provide controlled continuous release of a constant level of hormone over a period of 60 days (i.e., 80 g͞kg per day). This E 2 dose has previously been defined as adequate for a maximal effect on vascular functions in female mice (9, 19) . Mice were killed by an overdose of ketamine after 2 weeks of treatment. To measure serum E 2 concentrations, RIA kits for E 2 were used according to the manufacturer's instructions (Sorin Biomedica, Saluggia, Italy).
Endothelial EDRF͞NO Production in Isolated Vascular
Ring Experiments. Endothelial EDRF͞NO production was measured as described (20) . Briefly, the two distal ring segments of 3 mm were obtained from the descending thoracic aorta. They were suspended in individual organ chambers filled with Krebs buffer (5 ml) with the following composition: 118.3 mM NaCl͞4.69 mM KCl͞1.25 mM CaCl 2 ͞1.17 mM MgSO 4 ͞1.18 mM K 2 HPO 4 ͞25.0 mM NaHCO 3 ͞11.1 mM glucose, pH 7.4. The solution was aerated continuously with 95% O 2 -5% CO 2 and maintained at 37°C. Care was taken not to injure the endothelium during ring preparation. Tension was recorded with a linear force transducer. The resting tension was gradually increased to 1 g over a period of 45 min, and the vessels were left at this resting tension throughout the remainder of the study. One gram was determined as the optimal resting tension of aortic rings to develop the maximal contraction in response to 80 mM KCl (20) . The vessels were contracted with L-phenylephrine (3 M) to determine maximal contraction, then they were precontracted to 80% of that value (phenylephrine, 0.25 M). When a stable contraction plateau had been reached, the rings were exposed cumulatively to either acetylcholine (1 nM-30 M), A23187 (1 nM-1 M), or sodium nitroprusside (0.1 nM-0.3 M). Experiments were performed in the presence of the cyclooxygenase inhibitor diclofenac (2 M).
Basal NO production by aortic ring was evaluated from the contraction elicited after 30 min with N G -nitro-L-arginine (final concentration, 100 M) added to rings preconstricted for 30 min with the thromboxane A 2 mimetic U46619 (7.5 nM). Data were collected by ACKNOWLEDGE software (Biopac System, Santa Barbara, CA), and relaxation was expressed as the percentage tension decrease below the tension elicited by precontracting the aortic rings with phenylephrine.
RNA Isolation and Reverse Transcriptase (RT)-PCR.
After killing, tissues were frozen in liquid nitrogen before homogenization. Total RNA was extracted from uterine and aortic tissues by using RNAble (Eurobio, Paris). The absorbance ratio of RNA͞ proteins at 260͞280 nm was between 1.8 and 1.9. In the present study, we used the description of the oligonucleotides and the terminology recently described by Kos et al. (16) . All positions were according to the cDNA sequence cloned by White et al. (21) (Fig. 1) . Total RNA was reverse-transcribed by using the SuperScript First-Strand Synthesis System (Life Technologies, Rockville, MD; GIBCO͞BRL) as described by the manufacturer with a gene-specific primer I (5Ј-ATAAACAGAATAGAT-CATGG-3Ј), which is complementary to nucleotides 219-239 of exon 4 of mouse ER␣. The product was then used as a template for PCR by using a nested downstream primer II specific for exon 4 (5Ј-GCACTGACCATCTGGTCAGC-3Ј) and an upstream primer P specific for exon leader F2 (5Ј-GCTGTCTCCTCAAA-CACATCC-3Ј). Amplified products were separated by agarose gel electrophoresis. After recuperation, fragments were automatically sequenced by using AmpliTaq FS (Perkin-Elmer) with a nested primer III (5Ј-CCAAGTCATCTCTCTGACGCTTG-3Ј) specific for exon 4.
Western Blot Analysis. One hundred micrograms of whole aortic or uterus tissue extracts was subjected to SDS͞PAGE, after protein denaturation at 95°C for 3 min, on a 10% SDS͞polyacrylamide gel with prestained size markers (BenchMark, GIBCO͞BRL, Life Technologies). After electrotransfer onto a nitrocellulose membrane (Protran BA83, Schleicher & Schuell), the membrane was blocked in TBST-3% milk (25 mM Tris͞140 mM NaCl͞0.1% Tween, pH 8͞3% nonfat milk powder). The membrane was then incubated with either a rabbit polyclonal antibody (MC20, directed toward the common C-terminal domain of the different ER␣ isoforms, Santa Cruz Biotechnology) or a mAb (1D5, which recognizes a sequence localized around the 119th amino acid of the A͞B domain, Dako), 0.3 g͞ml in TBST-1% nonfat milk powder. After incubation with a peroxidase-coupled goat antirabbit antibody, ER␣ proteins were visualized by using the ECL system (Amersham Pharmacia) according to the manufacturer's instructions.
Immunohistochemistry. Formalin-fixed, paraffin-embedded blocks of uterus and aorta were cut as 6-m sections (microtome Leica CM 1900). Immunohistochemical assays (on Tech Mate Horizon, Dako) with MC20 antibody (dilution of 1:600) were performed by using a modification of the antigenretrieval technique based on microwave exposure (22) . Endogenous peroxidase activity was quenched by using a 3% hydrogen peroxide͞methanol solution. The sections were incubated with the horseradish peroxidase-conjugated rabbit anti-mouse IgG (EnVision, Dako). To visualize MC20 antibody binding, tissue sections were incubated in 3,3Ј-diaminobenzydine, rinsed in distilled water, and counterstained in Gill's hematoxylin. Slides were prepared for analysis by standard light microscopy.
Statistical Analysis. Data were expressed as mean Ϯ SE. Comparisons of concentration-response relaxations between the various aortic segments studied were made by one-factor ANOVA. Comparisons of data between different groups were made with repeated measures and a Scheffe's post hoc test used when differences were indicated. When an interaction was observed between the two factors, the effect of E 2 treatment was studied in each genotype by using a t test. P Ͻ 0.05 was considered statistically significant.
Results
Effect of E2 on Uterus Weight. Ovariectomized mice implanted with a placebo pellet showed nondetectable (Ͻ 5 pg͞ml, i.e., Ͻ 20 ϫ 10 Ϫ12 M) circulating levels of E 2 and atrophied uterus (Ͻ 20 mg). The ovariectomized mice implanted with a pellet releasing 0.1 mg of E 2 for 60 days (i.e., 80 g͞kg per day) showed serum E 2 concentrations averaging 0.5 ϫ 10 Ϫ9 M, irrespective of the genotype. As expected, ovariectomized ER␣-WT mice treated with E 2 presented a significant increase in uterine weight. ER␣-⌬2 KO mice showed no increase under E 2 treatment. ER␣-Neo KO mice showed a significant increase in uterine weight, although only partial when compared with WT mice (Table 1 and Fig. 2A ).
Effect of E2 on Endothelial EDRF͞NO Production. As previously reported in C57BL͞6 mice (20) , E 2 did not significantly alter the contraction of aortic rings in response to 80 mM KCl or to the ␣1-adrenergic agonist phenylephrine in ER␣-WT mice ( Table  1 ). The basal NO release (evaluated from the N G -nitro-Larginine-induced contraction obtained in U-46619 precontracted rings) was significantly enhanced by E 2 (Fig. 2B) . The vessels were precontracted to 80% of the maximal contraction by phenylephrine, and stimulated EDRF activity was estimated from the relaxation in response to acetylcholine. The EC 50 was significantly increased (about 2.3-fold), and the maximal relaxation was significantly decreased (29%) by E 2 in comparison to the placebo group (Fig. 2C and Table 1 ). The relaxation in response to the NO-releasing agent sodium nitroprusside was not influenced by E 2 (not shown).
Different responses were observed in ER␣-Neo KO and ER␣-⌬2 KO mice. Contraction and relaxation in mice of both KO genotypes, implanted with a placebo pellet, were similar to untreated ER␣-WT mice (Table 1 ). In ER␣-⌬2 KO mice, E 2 treatment did not alter basal NO release or acetylcholine-elicited relaxation ( Fig. 2 B and C and Table 1 ). In contrast, in ER␣-Neo KO mice, E 2 treatment significantly increased basal NO release (Fig. 2B) and decreased acetylcholine-elicited relaxation (increasing EC 50 about 3.9-fold, P Ͻ 0.01, and decreasing the maximal relaxation by 30%, P Ͻ 0.01; Fig. 2C and Table 1 ). Thus, the effect of E 2 on aortic NO production of ER␣-Neo KO (␣ERKO in ref. 12) mouse was the same as in ER␣-WT mice.
Identification of ER␣ mRNA Expressed in the Aorta of ER␣-WT, ER␣-⌬2
KO, and ER␣-Neo KO Mice. In the aorta of an ovariectomized WT mouse, two ER␣ mRNA variants were observed (Fig. 3A) . As shown by sequencing, the first one corresponded to the 1,075-bp PCR product (1: ER␣-WT mRNA), including the exon leader F2 but not A, B, or C exon leaders (see refs. 16 and 17) and encoding for the ''classical'' full-length ER␣ 66 protein through initiation of translation from AUG1 of exon 1 (Fig. 3B) . The second mRNA corresponded to the 540-bp PCR product (2: ER␣-⌬1 mRNA) resulting from the splicing of exon 1 (Fig. 3B) . This ER␣ mRNA would encode an ER␣ 46 isoform deleted for the Data for ER␣-⌬2 KO mice have been published (20) . Data are means Ϯ SE from the two distal rings of the thoracic aorta from five separate mice in each group.
A͞B domain. E 2 treatment did not alter the expression profile of ER␣ mRNA (not shown).
No RT-PCR products were generated from mRNA obtained in the aorta of ER␣-⌬2 KO mutant mouse. In contrast, expression of three different RT-PCR products (Fig. 3 A and B (1) mRNA was generated through a remodeling of exon 1 with a partial splicing out of 192 nts in the 3Ј part of exon 1 and of 1,779 nts in the C terminal of the Neo insert, leading to the persistence of an ORF able to encode for a chimeric ER␣55 protein through initiation of translation from the AUG1 in exon 1 (Fig. 3B) . This was similar to the observations reported by Couse et al. (14) . ER␣-Neo(2) mRNA was generated through the remodeling of exon 1 with a splicing out of 342 nts in the 3Ј part of exon 1 and the whole Neo insert, creating a frameshift and a stop codon in the 5Ј end of exon 2. Fragment 5, which had not been reported so far in ER␣-Neo KO mice, was indeed identical to the fragment 2 (ER␣-⌬1) obtained in ER␣-WT mice. Similar RT-PCR profiles were obtained in uterine tissues (data not shown).
Immunodetection of ER␣ Isoforms in the Aorta and the Uterus of WT,
ER␣-⌬2 KO, and ER␣-Neo KO Mice. Using the MC20 antibody directed toward the C-terminal domain (Fig. 4) , Western blot of uterus and aorta homogenates of ER␣-WT mouse revealed not only ER␣66, the classical full-length isoform of ER␣, but also another species in the uterus migrating at 46 kDa, which was undetectable in the aorta. The immunoreactivity was not altered by treatment with E 2 (data not shown). In ER␣-Neo KO mice, a species corresponding to ER␣55 was evidenced both in the uterus and the aorta. In addition, a 46-kDa species was detected in the uterus but was, again, undetectable in the aorta. After washing, the same membranes were blotted again with 1D5 antibody, directed toward the A͞B domain. Like the MC20 antibody, this antibody detected ER␣66 in WT homogenates but did not reveal any 55-kDa or 46-kDa species, as expected from the absence or modification of the A͞B domain. In marked contrast, in homogenates from ER␣-⌬2 KO mice, no immunoreactivity could be detected, providing a control for these experiments.
MC20 antibody was also used to localize ER␣ in paraffinembedded blocks of uterus and aorta of the three castrated strains treated with E 2 . As expected, the nuclei of the uterine smooth muscle of ER␣-WT were intensively stained (Fig. 5A) , whereas no immunoreactivity could be detected in ER␣-⌬2 KO (Fig. 5B) . Interestingly, staining of several nuclei and diffuse staining of the cytoplasm was noted in ER␣-Neo KO mice (Fig.  5C ). However, we were unable to detect ER␣ immunostaining in aorta from WT or ER␣-Neo KO and, of course, from ER␣-⌬2 KO mice (not shown).
Discussion
The cardiovascular protective effects of estrogen are well established, and the direct effects of the hormone on vascular tissues are now well recognized (23) . Using a mouse model of carotid arterial injury, Mendelsohn and his collaborators have shown that E 2 administration completely inhibits the vascular injury response in ovariectomized WT and ER␣-Neo KO (␣ERKO in ref. 12) mice (13, 24) . At the time, these observations were interpreted as indicating that estrogen inhibits the vascular injury response by an ER␣-independent pathway and therefore suggested that ER␤ could mediate the protective effects of E 2 on the vasculature. Studies demonstrating that ER␤ is expressed in vascular cells and tissues, and, in contrast to ER␣, that ER␤ mRNA expression increases in vascular endothelial and smooth muscle cells after vascular injury (25) (26) (27) , also suggested that ER␤ could play a central role in mediating the cardiovascular effects of E 2 (28, 29) . However, in subsequent studies, Karas et al. (30) showed that the effect of E 2 is similar in WT and in ␤ERKO mice, ruling out an essential role for ER␤ in the arterial wall. Finally, by using ER␣-⌬2 KO mice (ER␣KO mice in ref. 18 ), which represent a complete and unambiguous inactivation of ER␣, as well as ER␤KO mice (18), we demonstrated that, on its own, ER␣ mediates the effect of E 2 on re-endothelialization, endothelial NO production, and uterine hypertrophy (present work and refs. 19 and 20) .
In initial studies, several effects of E 2 in ER␣-Neo KO (␣ERKO) mice were investigated (14) . These studies showed some degree of uterine hypertrophy in response to E 2 under high dose or continuous treatment, as well as the preservation of an ER␣ reading frame that could encode for a smaller mutant ER␣, as a possible source for the residual uterus E 2 binding (14) . In the present study, we have characterized the presence of three ER␣ mRNA splice variants of the targeted ER␣-Neo gene: ER␣-Neo(1), ER␣-Neo(2), and ER␣-Neo(3) mRNA (Fig. 3 ) by using an upstream primer specific for exon leader F2 in the PCR step. Similar data were obtained by using a primer specific for exon leader C (data not shown), in agreement with Kos and colleagues (16) . ER␣-Neo(2) mRNA would encode for a truncated nonsense protein, but ER␣ϪNeo(1) mRNA encodes for a chimeric ER␣ protein (ER␣55) deleted for 64 aa of the B domain (amino acids 92-155), which are replaced by 7 aa encoded by a small portion of the Neo gene. ER␣-Neo(3) mRNA, which is identical to ER␣-⌬1 mRNA, would code for an isoform of ER␣ deleted for the A͞B domain (ER␣46). This latter isoform had been characterized at the mRNA and protein level in rat uterus and human cells (16, 17, 31, 32) . The N-terminal region of the full-length ER␣ harbors a ligandindependent transcriptional activation function AF-1 (33) (34) (35) (36) . AF-1 has been considered to act synergistically with the ligand-dependent activation function AF-2, contained in the C-terminal region, for full activity of the ER (34, 35, 37, 38) . As ER␣55 and the ER␣46 isoform share an alteration and absence of the AF-1 domain, respectively, all other domains being intact, disappearance of AF-1 function but maintenance of AF-2 function is expected (34) . Indeed, Couse et al. (14) and Chambon et al. (33, 34) have Fig. 4 . Western blot analysis of ER␣ isoform abundance in the uteri (U) and the thoracic aorta (A) from ovariectomized ER␣-WT (1), ER␣-⌬2 KO (2), or ER␣-Neo KO (3) mice. Antibody MC20 is directed toward the C-terminal domain and thus reveals all three isoforms (ER␣66, ER␣55, ER␣46), and antibody 1D5 recognizes a sequence around the 119th amino acid of A͞B domain and thus detects only ER␣66. Each Western blot is representative of three separate experiments. , and ER␣-Neo KO mice (C). MC20 antibody was used to localize ER␣ in paraffin-embedded blocks of uteri from the three castrated strains to which E 2 was given. Nuclei of uterus smooth muscle cells of ER␣-WT were intensively stained. No immunoreactivity was detected in ER␣-⌬2 KO mice. Nuclei and diffuse staining of the cytoplasm were observed in ER␣-Neo KO mice.
overexpressed and characterized in vitro the ER␣55 and ER␣46 proteins, respectively, and showed that they possesses estrogendependent transcriptional activity, although reduced when compared with the WT full-length ER␣66.
Our present data indicate that the effects of E 2 on NO production are likely to be mediated by ER␣55, as this isoform was the only one detected in aorta homogenates (Fig. 4) . The role of ER␣46 itself could not be established, as its abundance in the aorta was below the detection threshold of Western blot analysis, even after prolonged exposure. As the two ER␣ molecular isoforms, ER␣66 and ER␣46, are physiologically generated, the question arises as to whether they have distinct functions in vivo. It seems that the full-length ER␣66 (which harbors the transactivation function AF-1) mediates fertility in both males and females (39) , some vascular effects of E 2 , such as the angiogenic effect (40) , as well as inhibition of the constitution of fatty streak in apolipoprotein E-deficient mice (41) . Conversely, AF-1 of ER␣ (absent and altered in ER␣46 and ER␣55, respectively) could be at least in part dispensable to mediate the effect of E 2 on the uterine response (present study), the inhibition of smooth muscle hyperplasia in response to endoluminal carotid injury (13, 42) , and the endothelial production of NO (present study). Thus, the former hypotheses (30, 42) of a reciprocal functional redundancy between ER␣ and ER␤, or of the existence of a putative third isoform ''ER␥,'' seem to be ruled out. Moreover, our data further demonstrate that the ␣ERKO (designated here ER␣-Neo) mutation (12) that may lack the AF-1, but not the AF-2 activation function, is not an ER␣ null mutation, in contrast to the more recent ER␣KO (designated here ER␣-⌬2 KO) null mutation (18) . In this respect ␣ERKO mice might help in studies aimed at defining the role of ER␣ AF-1 in physiology and pathology.
